CNMD
Price
$62.61
Change
-$0.13 (-0.21%)
Updated
Mar 10 closing price
Capitalization
2.43B
43 days until earnings call
IDXX
Price
$436.48
Change
+$6.36 (+1.48%)
Updated
Mar 10 closing price
Capitalization
44.84B
50 days until earnings call
Ad is loading...

CNMD vs IDXX

Header iconCNMD vs IDXX Comparison
Open Charts CNMD vs IDXXBanner chart's image
CONMED
Price$62.61
Change-$0.13 (-0.21%)
Volume$686.21K
Capitalization2.43B
IDEXX Laboratories
Price$436.48
Change+$6.36 (+1.48%)
Volume$996.35K
Capitalization44.84B
CNMD vs IDXX Comparison Chart
Loading...
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNMD vs. IDXX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Hold and IDXX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CNMD: $62.61 vs. IDXX: $436.48)
Brand notoriety: CNMD and IDXX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNMD: 134% vs. IDXX: 133%
Market capitalization -- CNMD: $2.43B vs. IDXX: $44.84B
CNMD [@Medical Specialties] is valued at $2.43B. IDXX’s [@Medical Specialties] market capitalization is $44.84B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNMD’s FA Score shows that 1 FA rating(s) are green whileIDXX’s FA Score has 1 green FA rating(s).

  • CNMD’s FA Score: 1 green, 4 red.
  • IDXX’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than CNMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNMD’s TA Score shows that 5 TA indicator(s) are bullish while IDXX’s TA Score has 3 bullish TA indicator(s).

  • CNMD’s TA Score: 5 bullish, 6 bearish.
  • IDXX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CNMD is a better buy in the short-term than IDXX.

Price Growth

CNMD (@Medical Specialties) experienced а +7.34% price change this week, while IDXX (@Medical Specialties) price change was -0.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.41%. For the same industry, the average monthly price growth was -7.75%, and the average quarterly price growth was -4.35%.

Reported Earning Dates

CNMD is expected to report earnings on Apr 23, 2025.

IDXX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-2.41% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than CNMD($2.43B). IDXX has higher P/E ratio than CNMD: IDXX (52.87) vs CNMD (38.71). IDXX YTD gains are higher at: 5.573 vs. CNMD (-8.518). IDXX has higher annual earnings (EBITDA): 1.22B vs. CNMD (192M). IDXX has more cash in the bank: 454M vs. CNMD (24.3M). CNMD has less debt than IDXX: CNMD (974M) vs IDXX (1.07B). IDXX has higher revenues than CNMD: IDXX (3.66B) vs CNMD (1.25B).
CNMDIDXXCNMD / IDXX
Capitalization2.43B44.8B5%
EBITDA192M1.22B16%
Gain YTD-8.5185.573-153%
P/E Ratio38.7152.8773%
Revenue1.25B3.66B34%
Total Cash24.3M454M5%
Total Debt974M1.07B91%
FUNDAMENTALS RATINGS
CNMD vs IDXX: Fundamental Ratings
CNMD
IDXX
OUTLOOK RATING
1..100
5569
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
5218
PRICE GROWTH RATING
1..100
9762
P/E GROWTH RATING
1..100
9779
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNMD's Valuation (11) in the Medical Specialties industry is significantly better than the same rating for IDXX (85). This means that CNMD’s stock grew significantly faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (60) in the Medical Specialties industry is somewhat better than the same rating for CNMD (100). This means that IDXX’s stock grew somewhat faster than CNMD’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is somewhat better than the same rating for CNMD (52). This means that IDXX’s stock grew somewhat faster than CNMD’s over the last 12 months.

IDXX's Price Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for CNMD (97). This means that IDXX’s stock grew somewhat faster than CNMD’s over the last 12 months.

IDXX's P/E Growth Rating (79) in the Medical Specialties industry is in the same range as CNMD (97). This means that IDXX’s stock grew similarly to CNMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNMDIDXX
RSI
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
View a ticker or compare two or three
Ad is loading...
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABLYX26.56N/A
N/A
American Beacon Large Cap Value Y
BKBDX12.48N/A
N/A
BlackRock Global Dividend K
LMVWX27.53N/A
N/A
Lord Abbett Focused Small Cap Value R6
CUSEX33.19-0.82
-2.41%
Capital Group US Equity
RSLAX53.35-1.53
-2.79%
American Funds SMALLCAP World R1

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with MYGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
-0.21%
MYGN - CNMD
45%
Loosely correlated
-5.50%
FLGT - CNMD
42%
Loosely correlated
-9.09%
SIBN - CNMD
38%
Loosely correlated
-3.86%
BDX - CNMD
38%
Loosely correlated
-0.46%
AVNS - CNMD
37%
Loosely correlated
-2.23%
More

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+1.48%
MYGN - IDXX
48%
Loosely correlated
-5.50%
TFX - IDXX
41%
Loosely correlated
-0.99%
IQV - IDXX
41%
Loosely correlated
-1.49%
SYK - IDXX
40%
Loosely correlated
-2.42%
SONVY - IDXX
40%
Loosely correlated
-0.75%
More